Harvard Management Co. CEO Jane Mendillo tells CNBC's Kelly Evans she has no regrets when it comes to her money management decisions. Mendillo plans to leave her position at the end of 2014.
Michael Novogratz, Fortress Investment Group principal, explains his investment focus outside of the United States.
Stanley Druckenmiller, retired founder of hedge fund firm Duquesne Capital Management, was a featured guest at the the Delivering Alpha conference presented by CNBC and Institutional Investor, where he explained why he's not as aggressive as he used to be and who he thinks is today's hottest investor.
The "Fast Money Halftime Report" traders dig into some of the major investment and Fed commentary out of CNBC's Delivering Alpha conference.
Discussing Fed Chair Janet Yellen's comments on overstretched valuations in some sectors, and just what could go wrong with the Fed's plan, with Michael Novogratz, Fortress Investment Group Principal.
CNBC's Dominic Chu reports Leon Cooperman's best ideas at CNBC's Delivering Alpha conference include Citi and SuperValu, and Larry Robbins likes Thermo Fisher. The FMHR traders share their opinions.
CNBC's Joe Kernen speaks to Stan Druckenmiller, Duquesne Capital Management founder, about his view of the impact of the Federal Reserve's QE program. He says he would make more market bets, but he just doesn't have the guts anymore.
CNBC's Joe Kernen speaks to Stan Druckenmiller, Duquesne Capital Management founder, about the current IPO and corporate credit market. Druckenmiller says IPO's are on the border of where they were in 1999.
Stan Druckenmiller, Duquesne Capital Management founder, discusses the Fed's "aggressive" policy on deflation and interest rates. Druckenmiller says the current policy makes no sense from a risk-reward perspective.
Stan Druckenmiller, Duquesne Capital Management founder, gives his views on Fed policy and leadership of the Federal Reserve during the financial crisis.
Larry Robbins, founder of Glenview Capital Management, puts forth his best investment ideas for 2014. CNBC's Dominic Chu reports.
CNBC's Dominic Chu reports investor Leon Cooperman's best investment ideas for 2014.
Kara Swisher, Re/code co-executive editor, and Jon Steinberg, Daily Mail North America CEO, share their opinions on Rupert Murdoch's play for Time Warner and discuss the future of big media companies.
CNBC's Dominic Chu reveals what new and big ideas are currently being pitched at CNBC's Delivering Alpha conference.
CNBC's Kelly Evans recaps her conversations about the ever-changing global market landscape with some world class investors.
CNBC's Kate Kelly speaks to Citadel founder and CEO Ken Griffin, about Time Warner's rejection of 21st Century Fox's takeover bid, and whether he expects more consolidation in the media space.
Mary Callahan Erdoes, CEO of J.P. Morgan Asset Management, discusses her concern about retail investors investing in bonds despite the growing risks.
CNBC's Steve Liesman discusses Treasury Secretary Jack Lew's comments on whether it's appropriate for the Fed to comment on valuations.
CNBC's Kate Kelly speaks to Citadel founder and CEO Ken Griffin, about the practice of payment for order flow, and new technologies involved in investing.
Treasury Secretary Jack Lew talks with CNBC's Jim Cramer about the evolution of trade agreements and the real power of China. Lew says the global economy depends on a good U.S. China relationship.
On July 18 2018 CNBC and Institutional Investor will host the 8th Annual Delivering Alpha Conference, an incomparable who's who of the investor community with leading asset manager, institutional investors, illustrious political and economic commentators.
Register early for the 8th annual Delivering Alpha conference on July 18, 2017
Jamie Dimon ripped the state of the U.S. economy, saying growth is being held back by a lack of action in Washington.
The Edge explores the limitless potential of innovation.
A globe-trotting look at the world of investing, from developed Europe and Asia trends to the least-traveled frontier markets.
Take an in-depth look at the world of modern medicine - examining the treatments, companies and people making a difference in the way we treat illness and injuries today, and laying the foundation for the medical treatments of tomorrow.